GLIMISAVE MV 3.3 Tab

About

Glimisave Mv 3.3 Tab is a comprehensive oral antidiabetic medication designed for the management of type 2 diabetes mellitus. It typically combines three active ingredients: Glimepiride, Metformin, and Voglibose. Glimepiride, a sulfonylurea, stimulates the pancreatic beta cells to release more insulin, thereby lowering blood glucose levels. Metformin, a biguanide, primarily reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues, while also decreasing intestinal glucose absorption. Voglibose, an alpha-glucosidase inhibitor, works by delaying the digestion and absorption of carbohydrates from the gastrointestinal tract, which helps to mitigate post-meal blood sugar spikes.

This triple-drug formulation is prescribed when diet, exercise, and single or dual oral antidiabetic agents are insufficient to achieve adequate glycemic control. By targeting multiple pathways involved in glucose regulation, Glimisave Mv 3.3 Tab aims to provide robust blood sugar management, reduce HbA1c levels, and help prevent the progression of long-term diabetic complications. Regular monitoring of blood glucose, kidney function, and liver function is crucial during the course of treatment to ensure safety and efficacy.

Uses

• Management of type 2 diabetes mellitus.
• Improvement of glycemic control in adults.
• When diet, exercise, and other medications are insufficient.
• Prevention of post-meal blood sugar spikes.

Directions For Use

Take this medicine orally with food, as directed by your physician, usually with the first main meal of the day. Swallow the tablet whole; do not crush or chew it.

Benefits

• Provides comprehensive blood sugar control.
• Reduces both fasting and post-meal glucose levels.
• Improves insulin sensitivity in the body.
• Helps lower HbA1c levels effectively.
• Reduces the risk of long-term diabetic complications.
• Offers a multi-pronged approach to diabetes management.

Side Effects

• Hypoglycemia (low blood sugar)
• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Flatulence
• Headache
• Dizziness
• Metallic taste in mouth
• Skin rash
• Lactic acidosis (rare but serious)
• Vitamin B12 deficiency (with long-term Metformin use)

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it can increase the risk of hypoglycemia and lactic acidosis, especially with Metformin.
• Pregnancy - Generally not recommended during pregnancy. Consult your doctor as insulin therapy is often preferred for glycemic control in pregnant women with diabetes.
• Breastfeeding - Not recommended during breastfeeding as components may pass into breast milk and could affect the infant. Discuss alternatives with your healthcare provider.
• Liver - Use with caution in patients with liver impairment as it may increase the risk of lactic acidosis (Metformin) and affect drug metabolism. Regular liver function monitoring is advised.
• Kidney - Contraindicated in severe kidney impairment due to the risk of lactic acidosis with Metformin accumulation. Dose adjustment or discontinuation may be necessary based on kidney function.
• Lung - No specific contraindication for lung conditions, but severe respiratory insufficiency could potentially increase the risk of lactic acidosis. Use with caution in such cases.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.